HomeTHYROCARE • NSE
add
Thyrocare Technologies Ltd
Previous close
₹1,266.10
Day range
₹1,275.00 - ₹1,298.00
Year range
₹658.00 - ₹1,474.00
Market cap
68.39B INR
Avg Volume
611.08K
P/E ratio
53.20
Dividend yield
1.36%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 2.17B | 22.09% |
Operating expense | 634.00M | 2.82% |
Net income | 479.90M | 79.94% |
Net profit margin | 22.16 | 47.34% |
Earnings per share | — | — |
EBITDA | 713.00M | 50.31% |
Effective tax rate | 23.60% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.92B | 39.87% |
Total assets | 6.80B | 13.92% |
Total liabilities | 1.46B | 34.77% |
Total equity | 5.34B | — |
Shares outstanding | 53.05M | — |
Price to book | 12.56 | — |
Return on assets | — | — |
Return on capital | 26.47% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 479.90M | 79.94% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,822
